← Back
$VRCA All transactions

Verrica Pharmaceuticals Inc.

▲ BUY
6 / 10

Conviction

$ Value

Shares

2,500

Price

Filed

Nov 25

Why this score? (6/10)
  • Open market buy (+3)
  • Cluster: 5 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Zawitz David

Title

Chief Operating Officer

CIK

0002046750

Roles

Officer

Transaction Details

Transaction Date

2025-11-25

Code

P

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,500

Footnotes

Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. | Immediately exercisable. | The reported securities are included within 10,000 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

Filing Info

Accession No.

0002046750-25-000004

Form Type

4

Issuer CIK

0001660334

Zawitz David's History

Date Ticker Type Value
2025-11-25 VRCA $42K
2025-11-25 VRCA

Other Insiders at VRCA (90d)

No other insider activity at this issuer in the last 90 days.